According to Emergent BioSolutions 's latest financial reports the company's total liabilities are A$1.44 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-12-31 | A$1.45 B | -15.38% |
2023-12-31 | A$1.72 B | -34.08% |
2022-12-31 | A$2.61 B | 40.76% |
2021-12-31 | A$1.85 B | -0.58% |
2020-12-31 | A$1.86 B | 5.56% |
2019-12-31 | A$1.76 B | 2.3% |
2018-12-31 | A$1.72 B | 755.19% |
2017-12-31 | A$0.20 B | -61.01% |
2016-12-31 | A$0.51 B | 0.11% |
2015-12-31 | A$0.51 B | 10% |
2014-12-31 | A$0.47 B | 205.64% |
2013-12-31 | A$0.15 B | 31.16% |
2012-12-31 | A$0.11 B | -7.42% |
2011-12-31 | A$0.12 B | 1.71% |
2010-12-31 | A$0.12 B | 11.13% |
2009-12-31 | A$0.11 B | -13.36% |
2008-12-31 | A$0.12 B | 10.71% |
2007-12-31 | A$0.11 B | -7.52% |
2006-12-31 | A$0.12 B | 128.15% |
2005-12-31 | A$55.48 M | -6.88% |
2004-12-31 | A$59.58 M | |
2002-12-31 | A$33.07 M | -70.75% |
2001-12-31 | A$0.11 B |